527 related articles for article (PubMed ID: 33321195)
1. SARS-CoV-2 infections among healthcare workers at Helsinki University Hospital, Finland, spring 2020: Serosurvey, symptoms and risk factors.
Kantele A; Lääveri T; Kareinen L; Pakkanen SH; Blomgren K; Mero S; Patjas A; Virtanen J; Uusitalo R; Lappalainen M; Järvinen A; Kurkela S; Jääskeläinen AJ; Vapalahti O; Sironen T
Travel Med Infect Dis; 2021; 39():101949. PubMed ID: 33321195
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
Trieu MC; Bansal A; Madsen A; Zhou F; Sævik M; Vahokoski J; Brokstad KA; Krammer F; Tøndel C; Mohn KGI; Blomberg B; Langeland N; Cox RJ;
J Infect Dis; 2021 Feb; 223(4):589-599. PubMed ID: 33247924
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland.
Kasztelewicz B; Janiszewska K; Burzyńska J; Szydłowska E; Migdał M; Dzierżanowska-Fangrat K
PLoS One; 2021; 16(4):e0249550. PubMed ID: 33793673
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Anti-SARS-CoV-2 Specific Antibodies in Health-Care Workers Compared to General Population during an Early Phase of the Pandemic, Tehran-Iran.
Mortezagholi S; Rostamzadeh D; Alinejad M; Younesi V; Tabarsi P; Shabani M
Iran J Immunol; 2021 Mar; 18(1):82-92. PubMed ID: 33787517
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.
Iruretagoyena M; Vial MR; Spencer-Sandino M; Gaete P; Peters A; Delgado I; Perez I; Calderon C; Porte L; Legarraga P; Anderson A; Aguilera X; Vial P; Weitzel T; Munita JM
BMC Infect Dis; 2021 May; 21(1):478. PubMed ID: 34039287
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.
Khan MS; Haq I; Qurieshi MA; Majid S; Bhat AA; Qazi TB; Chowdri IN; Sabah I; Kawoosa MF; Lone AA; Nabi S; Sumji IA; Obaid M; Kousar R
J Hosp Med; 2021 May; 16(5):274-281. PubMed ID: 33929947
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals.
Alserehi HA; Alqunaibet AM; Al-Tawfiq JA; Alharbi NK; Alshukairi AN; Alanazi KH; Bin Saleh GM; Alshehri AM; Almasoud A; Hashem AM; Alruwaily AR; Alaswad RH; Al-Mutlaq HM; Almudaiheem AA; Othman FM; Aldakeel SA; Abu Ghararah MR; Jokhdar HA; Algwizani AR; Almudarra SS; Albarrag AM
Diagn Microbiol Infect Dis; 2021 Mar; 99(3):115273. PubMed ID: 33296851
[TBL] [Abstract][Full Text] [Related]
8. The reliability of SARS-CoV-2 IgG antibody testing - a pilot study in asymptomatic health care workers in a Croatian university hospital.
Lapić I; Rogić D; Šegulja D; Kralik Oguić S; Knežević J
Croat Med J; 2020 Dec; 61(6):485-490. PubMed ID: 33410294
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence study of SARS-CoV-2 antibodies in healthcare workers following the first wave of the COVID-19 pandemic in a tertiary-level hospital in the south of Ireland.
Faller E; Wyse A; Barry R; Conlon K; Everard C; Finnegan P; Foran C; Herlihy E; Kerr G; Lapthorne S; McGreal-Bellone A; Morrissey E; O'Sullivan D; O'Sullivan G; Eustace JA; Spillane D; Dempsey C; Benson J; Prentice M; Gallagher J; MacSharry J; Fanning LJ; O'Riordan S; Horgan M; Sadlier C
BMJ Open; 2021 Jun; 11(6):e051415. PubMed ID: 34103324
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts.
Kataria Y; Cole M; Duffy E; de la Cena K; Schechter-Perkins EM; Bouton TC; Werler MM; Pierre C; Ragan EJ; Weber SE; Jacobson KR; Andry C
Sci Rep; 2021 May; 11(1):9694. PubMed ID: 33958668
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.
Musa S; Abdel Alem S; Amer K; Elnagdy T; Hassan WA; Ali MA; Gaber Y; Badary HA; Tantawi O; Abdelmoniem R; Radwan A; Yousof H; Shawky S; Talaat H; Fouad R; Kassem AM
J Infect Public Health; 2021 Oct; 14(10):1466-1473. PubMed ID: 34175238
[TBL] [Abstract][Full Text] [Related]
12. Prospective observational study and serosurvey of SARS-CoV-2 infection in asymptomatic healthcare workers at a Canadian tertiary care center.
Ferreira VH; Chruscinski A; Kulasingam V; Pugh TJ; Dus T; Wouters B; Oza A; Ierullo M; Ku T; Majchrzak-Kita B; Humar ST; Bahinskaya I; Pinzon N; Zhang J; Heisler LE; Krzyzanowski PM; Lam B; Lungu IM; Manase D; Pace KM; Mashouri P; Brudno M; Garrels M; Mazzulli T; Cybulsky M; Humar A; Kumar D
PLoS One; 2021; 16(2):e0247258. PubMed ID: 33592074
[TBL] [Abstract][Full Text] [Related]
13. Source and symptoms of COVID-19 among hospital workers in Milan.
Mandić-Rajčević S; Masci F; Crespi E; Franchetti S; Longo A; Bollina I; Velocci S; Amorosi A; Baldelli R; Boselli L; Negroni L; Zà A; Orfeo NV; Ortisi G; Centanni S; Colosio C
Occup Med (Lond); 2020 Dec; 70(9):672-679. PubMed ID: 33269398
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil.
Buonafine CP; Paiatto BNM; Leal FB; de Matos SF; de Morais CO; Guerra GG; Martuchelli MVV; Oliveira DBL; Durigon EL; Soares CP; Candido ED; Telezynski BL; Sáfadi MAP; Almeida FJ
BMC Infect Dis; 2020 Dec; 20(1):917. PubMed ID: 33267836
[TBL] [Abstract][Full Text] [Related]
15. The seroprevalence of SARS-CoV-2 in a rural southwest community.
Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.
Allen N; Riain UN; Conlon N; Ferenczi A; Carrion Martin AI; Domegan L; Walsh C; Doherty L; O'Farrelly C; Higgins E; Kerr C; McGrath J; ; Fleming C; Bergin C
Epidemiol Infect; 2021 Apr; 149():e157. PubMed ID: 33902786
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of anti-SARS-CoV-2 IgG among healthcare workers of a large university hospital in Milan, Lombardy, Italy: a cross-sectional study.
Lombardi A; Mangioni D; Consonni D; Cariani L; Bono P; Cantù AP; Tiso B; Carugno M; Muscatello A; Lunghi G; Pesatori AC; Riboldi L; Ceriotti F; Bandera A; Gori A
BMJ Open; 2021 Feb; 11(2):e047216. PubMed ID: 33619203
[TBL] [Abstract][Full Text] [Related]
18. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.
Brandstetter S; Roth S; Harner S; Buntrock-Döpke H; Toncheva AA; Borchers N; Gruber R; Ambrosch A; Kabesch M
Pediatr Allergy Immunol; 2020 Oct; 31(7):841-847. PubMed ID: 32413201
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi Arabia.
Alhabbab RY; Alsaieedi A; Algaissi A; Almahboub S; Al-Raddadi RM; Shabouni OI; Alhabbab R; Alfaraj AA; Alamri SS; Aljehani ND; Abdulal RH; Alfaleh MA; Abujamel TS; Alkayyal AA; Mahmoud AB; Abuzenadah AM; Hashem AM
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372618
[TBL] [Abstract][Full Text] [Related]
20. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
